688073 Bide Pharmatech
- 46.29
- +0.16+0.35%
Bide Pharmatech News
Bide Pharmaceutical: An indicative announcement on the actual controller of the company\'s proposal that the company buy back the shares again
Bide Pharmaceutical: Announcement on holding the results briefing for the third quarter of 2024
An indicative announcement on the actual controller of the company\'s proposal that the company repurchase shares again
Announcement on holding the results briefing for the third quarter of 2024
Announcement on shareholders\' completion of non-transactional account transfers
Bide Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Bide Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Bide Pharmaceuticals: third quarter report 2024
Third Quarter Report 2024
Bide Pharmaceutical: 2024 First Extraordinary General Meeting of Shareholders Meeting Information
Notice on the use of some temporarily idle funds raised for cash management
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement on renewing the Company\'s 2024 Audit Institution
Inspection opinions of Haitong Securities Co., Ltd. on Shanghai Bide Pharmaceutical Technology Co., Ltd. changing part of the fund-raising project and extending the implementation period
Announcement on changing part of the content of the fund-raising project and extending the implementation period
Inspection opinion of Haitong Securities Co., Ltd. on the development of foreign exchange hedging business by Shanghai Bide Pharmaceutical Technology Co., Ltd.
Announcement on plans to launch foreign exchange hedging business
Announcement of Resolutions of the Eighth Meeting of the Second Board of Supervisors
Analysis
Price Target
No Data
No Data